BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 22, 2008
View Archived Issues
Mutations behind Duane's retraction syndrome identified
Read More
Background data on CR-845 presented during recent World Congress on Pain
Read More
Preliminary phase II results show pain relief with XEN-2127 in oncology patients
Read More
Terlipressin benefits patients awaiting liver transplant with renal failure, hyponatremia
Read More
ALK-Abello reports positive results from phase II/III of allergy vaccine against dust mites
Read More
Rosetta enters collaboration with NIH to identify microRNAs involved in HIV viral replication
Read More
Pipex acquires AT-001 for rheumatoid arthritis
Read More
DelSite files IND with the FDA for phase I safety and immunogenicity study of GelVac
Read More
New therapeutic agents for obesity described in recent patents
Read More
Recent patent literature discloses new anticancer agents
Read More
New treatment options for osteoporosis disclosed in recent Novartis patent
Read More
V-2006 development for Parkinson's disease advances
Read More
Biovex receives regulatory clearance to begin studies with ImmunoVEX-HSV2
Read More
PolyMedix commences dosing in phase I novel systemic antibiotic trial
Read More
Repros reports no tumors in completed Proellex animal carcinogenicity study
Read More
Vidaza receives expanded FDA approval in high-risk MDS patients
Read More
Metvix prevents precancerous lesions in transplant patients
Read More
Ardea Biosciences commences phase I trials for gout candidate RDEA-594
Read More
Cymbalta approved in Europe for the treatment of generalized anxiety disorder
Read More
FDA fast tracks ferumoxytol for vascular-enhanced magnetic resonance imaging
Read More
Phase III trial commences for Nexavar as adjuvant therapy in liver cancer
Read More
Auris Medical reports results of phase I/II AM-101 trial
Read More